Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has been designated the top-ranked medical technology firm in Clarivate’s Top 100 Global Innovators 2025. This marks the company’s 12th consecutive year on the list, solidifying its position as a leading innovator in the healthcare sector.
“At Philips, we’ve been innovating for over 130 years to improve people’s lives. Innovation is our fundamental strength, the reason why customers choose us as their strategic partner and a key value driver for our company,” stated Roy Jakobs, CEO of Royal Philips. He added, “Our portfolio of patient- and people-centric innovations in hardware, software, AI, and services enhances healthcare efficiency and empowers individuals to manage their own health and well-being, resulting in improved care for a greater number of people.”
In 2024, Philips invested approximately EUR 1.7 billion, representing over 9% of its sales, in research and development. This investment is geared toward advancing care for more people. The company is increasingly focused on harnessing the potential of data and AI. Philips allocates roughly half of its R&D workforce to these areas and leads in AI-related patent applications in healthcare. Examples of Philips’ AI-powered innovations:
- The Philips CT 5300 integrates hardware, software, and AI to deliver high-quality screening, diagnostic, and interventional imaging to a wider patient population.
- The latest SmartSpeed Precise MRI technology speeds up scans by up to three times while maintaining excellent image quality.
- The next-generation AI-enabled cardiovascular ultrasound platform features advanced AI tools to improve cardiovascular imaging and increase automation and productivity.
- The new Azurion image-guided therapy system and advanced informatics enhance minimally invasive diagnosis and treatment of stroke and neurovascular conditions.
The Top 100 Global Innovators assessment uses a thorough comparison of global invention data to evaluate the strength of patented ideas, based on their innovative capabilities. The comprehensive report is available here.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a health technology company focused on enhancing people’s health and well-being. Philips’ innovations employ advanced technology and clinical and consumer insights to provide personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and at home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. In 2024, Philips recorded sales of EUR 18 billion and employs around 67,800 people, with sales and services in over 100 countries. For more news about the company, visit www.philips.com/newscenter.
